Tranexamic acid (TXA) is widely used in hip and knee arthroplasty to reduce perioperative bleeding. Recently, its use has been expanded to arthroscopic surgery. The purpose of this study was to evaluate the efficacy of preoperative use of TXA in arthroscopic rotator cuff repair (RCR).
Methods
A cohort comprising 129 consecutive patients who underwent arthroscopic primary RCR at our institution was retrospectively investigated according to whether they received TXA (April 2018 to December 2020, TXA group, n = 64) or did not receive TXA (April 2016 to March 2018, non-TXA group, n = 65). TXA was administered at a dose of 1 g intravenously. Rotator cuff tears were repaired by the suture bridge technique. Videos of the arthroscopic procedures were reviewed and rated for visual clarity using a 10-point numeric rating scale. Arthroscopic procedures were divided into glenohumeral, resection of bursal tissue and acromioplasty, and RCR steps. Each step was rated separately. Age, sex, body mass index, hemoglobin level before and on days 1 and 7 after surgery, operating time, mean arterial pressure, tear size, and number of anchors used for cuff repair were compared between the two groups.
Results
There were no statistically significant differences in the patient demographic data. The operating time was significantly shorter in the TXA group than in non-TXA group (97.8 ± 21.8 min vs 116.2 ± 26.0 min). The clarity of the visual field was similar between the two groups during the glenohumeral phase but was significantly higher in the TXA group during the resection of bursal tissue and acromioplasty and RCR phases. Hemoglobin level was not significantly different between the groups on postoperative day 1 but was significantly higher in the TXA group on day 7.
Conclusion
Administration of a single intravenous dose of TXA improved visual clarity in arthroscopic RCR, decreased the total operating time, and reduced hemoglobin loss on postoperative day 7.
背景氨甲环酸（TXA）广泛应用于髋关节和膝关节置换术以减少围手术期出血。最近，它的应用已经扩展到关节镜手术。本研究的目的是评估术前使用TXA进行关节镜下肩袖修复（RCR）的疗效（2016年4月至2018年3月，非TXA组，n=65）。TXA以1g的剂量静脉内给药。采用缝合桥技术修复旋转袖撕裂。对关节镜手术的视频进行了审查，并使用10分数字评分表对其视觉清晰度进行了评分。关节镜手术分为肩关节、囊组织切除和肩峰成形术以及RCR步骤。每一步都是单独评分的。比较两组患者的年龄、性别、体重指数、术前和术后第1天和第7天的血红蛋白水平、手术时间、平均动脉压、撕裂大小和用于袖带修复的锚钉数量。结果患者人口学数据无统计学意义差异。TXA组的手术时间明显短于非TXA组（97.8±21.8min vs 116.2±26.0min）。两组在肩关节期的视野清晰度相似，但TXA组在囊组织切除、肩峰成形术和RCR期的视野清晰度明显较高。术后第1天，两组之间的血红蛋白水平没有显著差异，但在第7天，TXA组的血红蛋白水平显著升高。结论单次静脉注射TXA可提高关节镜下RCR的视觉清晰度，缩短总手术时间，并在术后第7天减少血红蛋白损失。
{"title":"Reduction of perioperative blood loss and operating time for arthroscopic rotator cuff repair by intravenous administration of tranexamic acid","authors":"Shinji Kawaguchi , Shoji Fukuta , Masashi Kano , Koichi Sairyo","doi":"10.1016/j.asmart.2023.01.001","DOIUrl":"10.1016/j.asmart.2023.01.001","url":null,"abstract":"<div><h3>Background</h3><p>Tranexamic acid (TXA) is widely used in hip and knee arthroplasty to reduce perioperative bleeding. Recently, its use has been expanded to arthroscopic surgery. The purpose of this study was to evaluate the efficacy of preoperative use of TXA in arthroscopic rotator cuff repair (RCR).</p></div><div><h3>Methods</h3><p>A cohort comprising 129 consecutive patients who underwent arthroscopic primary RCR at our institution was retrospectively investigated according to whether they received TXA (April 2018 to December 2020, TXA group, n = 64) or did not receive TXA (April 2016 to March 2018, non-TXA group, n = 65). TXA was administered at a dose of 1 g intravenously. Rotator cuff tears were repaired by the suture bridge technique. Videos of the arthroscopic procedures were reviewed and rated for visual clarity using a 10-point numeric rating scale. Arthroscopic procedures were divided into glenohumeral, resection of bursal tissue and acromioplasty, and RCR steps. Each step was rated separately. Age, sex, body mass index, hemoglobin level before and on days 1 and 7 after surgery, operating time, mean arterial pressure, tear size, and number of anchors used for cuff repair were compared between the two groups.</p></div><div><h3>Results</h3><p>There were no statistically significant differences in the patient demographic data. The operating time was significantly shorter in the TXA group than in non-TXA group (97.8 ± 21.8 min vs 116.2 ± 26.0 min). The clarity of the visual field was similar between the two groups during the glenohumeral phase but was significantly higher in the TXA group during the resection of bursal tissue and acromioplasty and RCR phases. Hemoglobin level was not significantly different between the groups on postoperative day 1 but was significantly higher in the TXA group on day 7.</p></div><div><h3>Conclusion</h3><p>Administration of a single intravenous dose of TXA improved visual clarity in arthroscopic RCR, decreased the total operating time, and reduced hemoglobin loss on postoperative day 7.</p></div>","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"31 ","pages":"Pages 6-10"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/33/main.PMC9937805.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9331517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<div><h3>Background</h3><p>Re-alignment surgeries for uni-compartmental knee osteoarthritis, such as high tibial osteotomy (HTO) for varus knees or distal femoral osteotomy (DFO) for valgus knees, are recognized as standard strategies. However, the treatment strategy has not been established for patients with a neutrally-aligned osteoarthritic knee with severe joint line obliquity (JLO) owing to the combination of a valgus femur and a varus tibia; i.e., type II coronal plane alignment of the knee (CPAK). total knee arthroplasty (TKA) can be an option for CPAK type II-aligned osteoarthritis in older inactive patients. Here, we hypothesized that joint line horizontalization by femoral-varus tibial-valgus osteotomy (FVTVO), which may reduce the shear stress induced by JLO, could be a treatment option for CPAK type II-aligned osteoarthritis in young active patients who wish to return to sports (RTS) activity. Our aim in this study was to evaluate the postoperative results of FVTVO with RTS.</p></div><div><h3>Methods</h3><p>Our indications for FVTVO are as follows: JLO >5°; mechanical medial proximal tibial angle (mMPTA) < 87°; mechanical lateral distal femoral angle (mLDFA) < 87°; typical osteoarthritis patterns for CPAK type II on magnetic resonance images, namely osteoarthritic change of the lateral tibial spine, medial slip of the femur, and/or lateral meniscal extrusion from the lateral femoral condyle; and flexion contracture <10°. We enrolled patients who wished to RTS and who had a pre-symptom Tegner score ≥5 and had completed at least a 1-year follow-up. For FVTVO, closed-wedge DFO was performed in all femurs; both closed-wedge HTO and open-wedge HTO were used in the tibia, depending on the situation. Range of motion exercises began on the first postoperative day, and full weight-bearing was permitted 6 weeks postoperatively. Jogging was permitted 3 months postoperatively after confirming bone union, and patients could gradually return to their sports activity 6–12 months’ postoperatively. The Japanese Orthopaedic Association (JOA) score and knee flexion range were assessed preoperatively and at the last follow-up. Tegner activity scale scores were assessed presymptom, preoperatively, and at the last follow-up. The hip-knee-ankle (HKA) angle, JLO, mMPTA, and mLDFA were evaluated radiologically, and meniscal extrusions, osteoarthritic change, and/or bone marrow edema were assessed on magnetic resonance images.</p></div><div><h3>Results</h3><p>One man and two women were included in this case series. Two were competitive athletes and one was a mountain climber. The patients' ages were 69, 46, and 57 years (Case 1, 2, and 3, respectively). All patients’ CPAK type was converted from type II to type V; i.e., neutral-aligned knee with a neutral joint line, postoperatively. All patients returned to their presymptom sports activity level by the final follow-up. The presymptom/preoperative/final follow-up Tegner scale in Case 1, 2, and 3 we
{"title":"Femoral-varus tibial-valgus osteotomy (FVTVO) for neutrally-aligned knee osteoarthritis with severe joint line obliquity enables return to sports activities: A case series study","authors":"Ryuichi Nakamura , Masaki Amemiya , Tomoyuki Shimakawa , Masaki Takahashi , Kazunari Kuroda , Yasuo Katsuki , Akira Okano","doi":"10.1016/j.asmart.2023.01.002","DOIUrl":"10.1016/j.asmart.2023.01.002","url":null,"abstract":"<div><h3>Background</h3><p>Re-alignment surgeries for uni-compartmental knee osteoarthritis, such as high tibial osteotomy (HTO) for varus knees or distal femoral osteotomy (DFO) for valgus knees, are recognized as standard strategies. However, the treatment strategy has not been established for patients with a neutrally-aligned osteoarthritic knee with severe joint line obliquity (JLO) owing to the combination of a valgus femur and a varus tibia; i.e., type II coronal plane alignment of the knee (CPAK). total knee arthroplasty (TKA) can be an option for CPAK type II-aligned osteoarthritis in older inactive patients. Here, we hypothesized that joint line horizontalization by femoral-varus tibial-valgus osteotomy (FVTVO), which may reduce the shear stress induced by JLO, could be a treatment option for CPAK type II-aligned osteoarthritis in young active patients who wish to return to sports (RTS) activity. Our aim in this study was to evaluate the postoperative results of FVTVO with RTS.</p></div><div><h3>Methods</h3><p>Our indications for FVTVO are as follows: JLO >5°; mechanical medial proximal tibial angle (mMPTA) < 87°; mechanical lateral distal femoral angle (mLDFA) < 87°; typical osteoarthritis patterns for CPAK type II on magnetic resonance images, namely osteoarthritic change of the lateral tibial spine, medial slip of the femur, and/or lateral meniscal extrusion from the lateral femoral condyle; and flexion contracture <10°. We enrolled patients who wished to RTS and who had a pre-symptom Tegner score ≥5 and had completed at least a 1-year follow-up. For FVTVO, closed-wedge DFO was performed in all femurs; both closed-wedge HTO and open-wedge HTO were used in the tibia, depending on the situation. Range of motion exercises began on the first postoperative day, and full weight-bearing was permitted 6 weeks postoperatively. Jogging was permitted 3 months postoperatively after confirming bone union, and patients could gradually return to their sports activity 6–12 months’ postoperatively. The Japanese Orthopaedic Association (JOA) score and knee flexion range were assessed preoperatively and at the last follow-up. Tegner activity scale scores were assessed presymptom, preoperatively, and at the last follow-up. The hip-knee-ankle (HKA) angle, JLO, mMPTA, and mLDFA were evaluated radiologically, and meniscal extrusions, osteoarthritic change, and/or bone marrow edema were assessed on magnetic resonance images.</p></div><div><h3>Results</h3><p>One man and two women were included in this case series. Two were competitive athletes and one was a mountain climber. The patients' ages were 69, 46, and 57 years (Case 1, 2, and 3, respectively). All patients’ CPAK type was converted from type II to type V; i.e., neutral-aligned knee with a neutral joint line, postoperatively. All patients returned to their presymptom sports activity level by the final follow-up. The presymptom/preoperative/final follow-up Tegner scale in Case 1, 2, and 3 we","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"31 ","pages":"Pages 11-17"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/f0/main.PMC9941361.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9600730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01Epub Date: 2022-04-18DOI: 10.1007/s00262-022-03201-9
Myeong Joon Kim, Kyeong Hee Hong, Bo Ryeong Lee, Sang-Jun Ha
Cancer immunotherapy, which blocks immune checkpoint molecules, is an effective therapeutic strategy for human cancer patients through restoration of tumor-infiltrating (TI) cell function. However, evaluating the efficacy of immune checkpoint inhibitors (ICIs) is difficult because no standard in vitro assay for ICI efficacy evaluation exists. Additionally, blocking a particular immune checkpoint receptor (ICR) is insufficient to restore T cell functionality, because other ICRs still transduce inhibitory signals. Therefore, limiting inhibitory signals transduced via other ICRs is needed to more accurately assess the efficacy of ICIs targeting a particular immune checkpoint. Here, we introduce a newly developed in vitro coculture assay using human peripheral blood mononuclear cells (hPBMCs) and engineered human cancer cell lines. We enriched CD8+ T cells from hPBMCs of healthy donors through low-dose T cell receptor stimulation and cytokine (human IL-2 and IL-7) addition. These enriched CD8+ T cells were functional and expressed multiple ICRs, especially TIM-3 and TIGIT. We also established immune checkpoint ligand (ICL) knockout (KO) cancer cell lines with the CRISPR-Cas9 system. Then, we optimized the in vitro coculture assay conditions to evaluate ICI efficacy. For example, we selected the most effective anti-TIM-3 antibody through coculture of TIM-3+CD8+ T cells with PD-L1-/-PVR-/- cancer cells. In summary, we developed a mechanism-based in vitro coculture assay with hPBMCs and ICL KO cancer cell lines, which could be a useful tool to identify promising ICIs by providing reliable ICI efficacy information.
癌症免疫疗法可阻断免疫检查点分子，通过恢复肿瘤浸润（TI）细胞的功能，是人类癌症患者的一种有效治疗策略。然而，评估免疫检查点抑制剂（ICIs）的疗效十分困难，因为目前还没有用于 ICI 疗效评估的标准体外检测方法。此外，阻断特定的免疫检查点受体（ICR）不足以恢复 T 细胞的功能，因为其他 ICR 仍在传递抑制信号。因此，需要限制通过其他 ICR 传递的抑制信号，以更准确地评估针对特定免疫检查点的 ICIs 的疗效。在此，我们介绍一种新开发的体外共培养试验，该试验使用人外周血单核细胞（hPBMCs）和工程化人癌细胞系。通过低剂量 T 细胞受体刺激和细胞因子（人 IL-2 和 IL-7）添加，我们从健康供体的 hPBMCs 中富集了 CD8+ T 细胞。这些富集的 CD8+ T 细胞具有功能性，并表达多种 ICRs，尤其是 TIM-3 和 TIGIT。我们还利用CRISPR-Cas9系统建立了免疫检查点配体（ICL）敲除（KO）癌细胞系。然后，我们优化了体外共培养试验条件，以评估 ICI 的功效。例如，我们通过 TIM-3+CD8+ T 细胞与 PD-L1-/-PVR-/- 癌细胞的共培养筛选出了最有效的抗 TIM-3 抗体。总之，我们用 hPBMCs 和 ICL KO 癌细胞系开发了一种基于机制的体外共培养试验，它可以提供可靠的 ICI 疗效信息，是一种识别有前景 ICI 的有用工具。
{"title":"Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors.","authors":"Myeong Joon Kim, Kyeong Hee Hong, Bo Ryeong Lee, Sang-Jun Ha","doi":"10.1007/s00262-022-03201-9","DOIUrl":"10.1007/s00262-022-03201-9","url":null,"abstract":"<p><p>Cancer immunotherapy, which blocks immune checkpoint molecules, is an effective therapeutic strategy for human cancer patients through restoration of tumor-infiltrating (TI) cell function. However, evaluating the efficacy of immune checkpoint inhibitors (ICIs) is difficult because no standard in vitro assay for ICI efficacy evaluation exists. Additionally, blocking a particular immune checkpoint receptor (ICR) is insufficient to restore T cell functionality, because other ICRs still transduce inhibitory signals. Therefore, limiting inhibitory signals transduced via other ICRs is needed to more accurately assess the efficacy of ICIs targeting a particular immune checkpoint. Here, we introduce a newly developed in vitro coculture assay using human peripheral blood mononuclear cells (hPBMCs) and engineered human cancer cell lines. We enriched CD8<sup>+</sup> T cells from hPBMCs of healthy donors through low-dose T cell receptor stimulation and cytokine (human IL-2 and IL-7) addition. These enriched CD8<sup>+</sup> T cells were functional and expressed multiple ICRs, especially TIM-3 and TIGIT. We also established immune checkpoint ligand (ICL) knockout (KO) cancer cell lines with the CRISPR-Cas9 system. Then, we optimized the in vitro coculture assay conditions to evaluate ICI efficacy. For example, we selected the most effective anti-TIM-3 antibody through coculture of TIM-3<sup>+</sup>CD8<sup>+</sup> T cells with PD-L1<sup>-/-</sup>PVR<sup>-/-</sup> cancer cells. In summary, we developed a mechanism-based in vitro coculture assay with hPBMCs and ICL KO cancer cell lines, which could be a useful tool to identify promising ICIs by providing reliable ICI efficacy information.</p>","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"6 1","pages":"2777-2789"},"PeriodicalIF":5.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10992221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75653984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-01Epub Date: 2021-05-11DOI: 10.1115/dmd2021-1038
Yinuo Zeng, Molly Acord, Tarana Parvez Kaovasia, Peng Miao, Junfeng Sun, Janaka Senarathna, Nicholas Theodore, Nitish Thakor, Amir Manbachi
Transcranial focused ultrasound stimulation is a neuromodulation technique that is capable of exciting or suppressing the neural network. Such neuro-modulatory effects enable the treatment of brain diseases non-invasively, such as treating stroke. The neuro-modulatory effect on cerebral hemodynamics has been monitored using laser speckle contrast imaging in animal studies. However, the bulky size and stationary nature of the imaging system constrains the application of this imaging technique on research that requires the animal to have different body positions or to be awake. We present the design of a system that combines a miniature microscope for laser speckle contrast imaging and transcranial focused ultrasound stimulation, as well as, test its capability to monitor cerebral hemodynamics during stimulation and compare the result with a benchtop imaging system.
{"title":"A MINIATURE LASER SPECKLE CONTRAST IMAGER FOR MONITORING OF THE NEURO-MODULATORY EFFECT OF TRANSCRANIAL FOCUSED ULTRASOUND STIMULATION.","authors":"Yinuo Zeng, Molly Acord, Tarana Parvez Kaovasia, Peng Miao, Junfeng Sun, Janaka Senarathna, Nicholas Theodore, Nitish Thakor, Amir Manbachi","doi":"10.1115/dmd2021-1038","DOIUrl":"10.1115/dmd2021-1038","url":null,"abstract":"<p><p>Transcranial focused ultrasound stimulation is a neuromodulation technique that is capable of exciting or suppressing the neural network. Such neuro-modulatory effects enable the treatment of brain diseases non-invasively, such as treating stroke. The neuro-modulatory effect on cerebral hemodynamics has been monitored using laser speckle contrast imaging in animal studies. However, the bulky size and stationary nature of the imaging system constrains the application of this imaging technique on research that requires the animal to have different body positions or to be awake. We present the design of a system that combines a miniature microscope for laser speckle contrast imaging and transcranial focused ultrasound stimulation, as well as, test its capability to monitor cerebral hemodynamics during stimulation and compare the result with a benchtop imaging system.</p>","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82545075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-01DOI: 10.1016/j.wse.2020.12.008
Anonymous
{"title":"Erratum regarding missing Declaration of Competing Interest statements in previously published articles","authors":"Anonymous","doi":"10.1016/j.wse.2020.12.008","DOIUrl":"https://doi.org/10.1016/j.wse.2020.12.008","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"24 1","pages":"49 - 49"},"PeriodicalIF":2.1,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.wse.2020.12.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44865794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-04-01DOI: 10.1016/J.JOCA.2018.02.627
M. Desai, T. Davis, E. Loudermilk, M. Depalma, C. Hunter, D. Lindley, N. Patel, D. Choi, M. Soloman, Anita K. Gupta, A. Buvanendran, L. Kapural
{"title":"6- and 12-Month Results of A Prospective, Multi-Center, Randomized, Trial Comparing Safety and Effectiveness of Cooled Radiofrequency Ablation to Corticosteroid Injection For Management of Osteoarthritic Knee Pain","authors":"M. Desai, T. Davis, E. Loudermilk, M. Depalma, C. Hunter, D. Lindley, N. Patel, D. Choi, M. Soloman, Anita K. Gupta, A. Buvanendran, L. Kapural","doi":"10.1016/J.JOCA.2018.02.627","DOIUrl":"https://doi.org/10.1016/J.JOCA.2018.02.627","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/J.JOCA.2018.02.627","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49462290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-09-25DOI: 10.1016/J.ASMART.2017.05.100
J. Yoon
{"title":"Clinical results of rotator cuff repair in patient of glenohumeral osteoarthritis","authors":"J. Yoon","doi":"10.1016/J.ASMART.2017.05.100","DOIUrl":"https://doi.org/10.1016/J.ASMART.2017.05.100","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"9 1","pages":"52"},"PeriodicalIF":2.1,"publicationDate":"2017-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/J.ASMART.2017.05.100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42998954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-09-25DOI: 10.1016/j.asmart.2017.05.263
Jia-yin Ma
{"title":"The primary outcomes of osteolytic lesion of greater tuberosity in calcific tendinitis of the shoulder","authors":"Jia-yin Ma","doi":"10.1016/j.asmart.2017.05.263","DOIUrl":"https://doi.org/10.1016/j.asmart.2017.05.263","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"9 1","pages":"112"},"PeriodicalIF":2.1,"publicationDate":"2017-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.asmart.2017.05.263","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42729992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/J.ASMART.2017.05.102
Huanghe Song, W. Qing
{"title":"Shoulder - Rotator cuff tear and disorderA comparison of clinical outcomes after arthroscopic rotator cuff repair using single-row, double-row and suture bridge technique","authors":"Huanghe Song, W. Qing","doi":"10.1016/J.ASMART.2017.05.102","DOIUrl":"https://doi.org/10.1016/J.ASMART.2017.05.102","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"9 1","pages":"52-53"},"PeriodicalIF":2.1,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/J.ASMART.2017.05.102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47829211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-07-01DOI: 10.1016/j.asmart.2017.05.167
Yoon-Seok Youm, S. Cho, Youngjin Choi, Y. Joo, Moon-Hee Bae
{"title":"How the results of conservative treatment for ACL tears are different by posterior tibial slope","authors":"Yoon-Seok Youm, S. Cho, Youngjin Choi, Y. Joo, Moon-Hee Bae","doi":"10.1016/j.asmart.2017.05.167","DOIUrl":"https://doi.org/10.1016/j.asmart.2017.05.167","url":null,"abstract":"","PeriodicalId":44283,"journal":{"name":"Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology","volume":"9 1","pages":"78"},"PeriodicalIF":2.1,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.asmart.2017.05.167","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48961339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号